DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...

This new system by Medtronic has the benefits of hybrid closed loop technology and has a high level of connectivity and convenience, making it easier to access and securely share real-time Continuous ...

Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 ...

The US Food and Drug Administration (FDA) has approved the MiniMed 770G (Medtronic) automated insulin delivery system for children aged 2 to 6 years. The 770G will also be available to older children ...

The MiniMed 770G was approved for kids aged 2 to 6. It will monitor their sugar levels and automatically adjust insulin with little or no input required. Type 1 diabetes patients need to monitor their ...

Medtronic plc MDT recently shared a comprehensive set of new data emphasizing the benefits of the MiniMed 780G insulin pump system. The latest findings demonstrate how the system addresses ...

Medtronic plc MDT recently announced the receipt of the CE Mark for its next generation closed loop insulin pump system, MiniMed 780G, for the treatment of type 1 diabetes in the age range of 7 to 80 ...

BRAMPTON, ON , Dec. 8, 2020 /CNW/ - Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) – the world's largest medical technology, services, and solutions company – has received a licence ...

Medtronic, a global leader in medical technology, announced it has received US Food and Drug Administration (FDA) approval of its MiniMed 770G hybrid closed loop system. This newest insulin pump ...

DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...